文献速递糖尿病肥胖与代谢综合征

代谢手术对2型糖尿病风险人群的获益因亚表型而异

Subphenotype-Dependent Benefits of Bariatric Surgery for Individuals at Risk for Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2025-01-01

研究将无2型糖尿病但BMI升高的2型糖尿病风险人群按Tübingen Cluster分型,在法国里尔发现队列和意大利罗马复制队列中接受代谢手术,德国图宾根对照队列接受行为矫正咨询。结果显示各聚类相对体重下降相似,但C5胰岛素抵抗和β细胞功能改善最强、糖尿病前期缓解率最高,且手术队列高危聚类转为低危聚类。

要点

  • 发现队列中C4占15.0%(n=121)、C5占22.3%(n=180)、C6占62.4%(n=503)。
  • 各聚类相对体重下降相似,但C5胰岛素抵抗下降和β细胞功能改善最强。
  • 糖尿病前期缓解率低危C4最低、高危C5最高,手术队列高危聚类转为低危聚类。

核心结论

  • C5参与者从代谢手术中获益最大,表现为胰岛素抵抗改善、β细胞功能改善和糖尿病前期缓解。
  • 这种新分型可能有助于识别将特别从代谢手术中获益的个体。

研究设计与样本

  • 将无2型糖尿病但BMI升高的2型糖尿病风险参与者按Tübingen Cluster分型,其血糖调节正常或为糖尿病前期(美国糖尿病协会标准)。
  • 两个队列接受代谢手术:发现队列(法国里尔)和复制队列(意大利罗马);对照队列(德国图宾根)接受行为矫正咨询。
  • 主要结局包括血糖调节参数变化和糖尿病前期缓解。

主要发现

  • 发现队列中15.0%的参与者(n=121)归入C4,22.3%(n=180)归入C5,62.4%(n=503)归入C6。
  • 各聚类相对体重下降相似;但胰岛素抵抗下降和β细胞功能改善在C5最强。
  • 糖尿病前期缓解率在低危C4最低、在高危C5最高。
  • 两个代谢手术队列中高危聚类个体转为低危聚类,而对照队列未出现此变化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Bariatric surgery is an effective treatment option for individuals with obesity and type 2 diabetes (T2D). However, whether outcomes in subtypes of individuals at risk for T2D and/or comorbidities (Tübingen Clusters) differ, is unknown. Of these, cluster 5 (C5) and cluster 6 (C6) are high-risk clusters for developing T2D and/or comorbidities, while cluster 4 (C4) is a low-risk cluster. We investigated bariatric surgery outcomes, hypothesizing that high-risk clusters benefit most due to great potential for metabolic improvement. RESEARCH DESIGN AND METHODS: We allocated participants without T2D but at risk for T2D, defined by elevated BMI, to the Tübingen Clusters. Participants had normal glucose regulation or prediabetes according to American Diabetes Association criteria. Two cohorts underwent bariatric surgery: a discovery (Lille, France) and a replication cohort (Rome, Italy). A control cohort (Tübingen, Germany) received behavioral modification counseling. Main outcomes included alteration of glucose regulation parameters and prediabetes remission. RESULTS: In the discovery cohort, 15.0% of participants (n = 121) were allocated to C4, 22.3% (n = 180) to C5, and 62.4% (n = 503) to C6. Relative body weight loss was similar among all clusters; however, reduction of insulin resistance and improvement of β-cell function were strongest in C5. Prediabetes remission rate was lowest in low-risk C4 and highest in high-risk C5. Individuals from high-risk clusters changed to low-risk clusters in both bariatric surgery cohorts but not in the control cohort. CONCLUSIONS: Participants in C5 had the highest benefit from bariatric surgery in terms of improvement in insulin resistance, β-cell function, and prediabetes remission. This novel classification might help identify individuals who will benefit specifically from bariatric surgery.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Sandforth L, Raverdy V, Sandforth A, et al. Subphenotype-Dependent Benefits of Bariatric Surgery for Individuals at Risk for Type 2 Diabetes. Diabetes Care. 2025. PMID: 40214701. doi:10.2337/dc25-0160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。